Literature DB >> 18594780

Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia.

Kuan-Po Huang1, Andrew J Chase2, Nicholas C P Cross2, Andrea Reiter3, Tzu-Ying Li4, Tso-Fu Wang1, Sung-Chao Chu1, Xuan-Yin Lu1, Chi-Cheng Li1, Ruey-Ho Kao5,6.   

Abstract

The rare recurrent translocation of (8;9)(p22;p24) with PCM1-JAK2 fusion was recently characterized in diverse hematological malignancies. Most of them are atypical chronic myeloid leukemia (CML) or other myeloproliferative disorders (MPD), and are predominantly in the male. We report a female patient with acute myeloid leukemia (AML) initially presenting with normal karyotype and negative HLA-DR expression who achieved complete remission after standard chemotherapy. The disease relapsed 7 months later with cytogenetic change of t(8;9)(p22;p24). Flow cytometry analysis showed evolutional change of immunophenotype from negative to positive HLA-DR expression and fluorescence in situ hybridization (FISH) analysis demonstrated a PCM1-JAK2 fusion gene. We speculate that the cytogenetic change of t(8;9)(p22;p24) may induce HLA-DR immunophenotypic switch and a coordination of the two evolutional changes may play a role in leukemic cell progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18594780     DOI: 10.1007/s12185-008-0113-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  26 in total

1.  Immunophenotypic and cytogenetic changes in acute leukaemia at relapse.

Authors:  M Hur; Y H Chang; D S Lee; M H Park; H I Cho
Journal:  Clin Lab Haematol       Date:  2001-06

2.  Interferon-gamma-induced JAK2 and STAT1 signalling in a human salivary gland cell line.

Authors:  A J Wu; Z J Chen; E C Kan; B J Baum
Journal:  J Cell Physiol       Date:  1997-10       Impact factor: 6.384

3.  Change in karyotype between diagnosis and first relapse in acute myelogenous leukemia.

Authors:  E Estey; M J Keating; S Pierce; S Stass
Journal:  Leukemia       Date:  1995-06       Impact factor: 11.528

4.  Differential effects of protein tyrosine kinase inhibitors on interferon-gamma-induction of major histocompatibility complex class II and intercellular adhesion molecule-1 expression in human corneal epithelial cells.

Authors:  M Iwata; Y Suzuki; Y Imai; Y Ono; M Sawa
Journal:  Jpn J Ophthalmol       Date:  2001 Jan-Feb       Impact factor: 2.447

5.  IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.

Authors:  G M O'Keefe; V T Nguyen; L L Ping Tang; E N Benveniste
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

6.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Authors:  Ross L Levine; Martha Wadleigh; Jan Cools; Benjamin L Ebert; Gerlinde Wernig; Brian J P Huntly; Titus J Boggon; Iwona Wlodarska; Jennifer J Clark; Sandra Moore; Jennifer Adelsperger; Sumin Koo; Jeffrey C Lee; Stacey Gabriel; Thomas Mercher; Alan D'Andrea; Stefan Fröhling; Konstanze Döhner; Peter Marynen; Peter Vandenberghe; Ruben A Mesa; Ayalew Tefferi; James D Griffin; Michael J Eck; William R Sellers; Matthew Meyerson; Todd R Golub; Stephanie J Lee; D Gary Gilliland
Journal:  Cancer Cell       Date:  2005-04       Impact factor: 31.743

7.  The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.

Authors:  Andreas Reiter; Christoph Walz; Ann Watmore; Claudia Schoch; Ilona Blau; Brigitte Schlegelberger; Ute Berger; Nick Telford; Shilani Aruliah; John A Yin; Danny Vanstraelen; Helen F Barker; Peter C Taylor; Aisling O'Driscoll; Fabio Benedetti; Cornelia Rudolph; Hans-Jochem Kolb; Andreas Hochhaus; Rüdiger Hehlmann; Andrew Chase; Nicholas C P Cross
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

8.  Interferon-gamma-induced MHC class I expression and defects in Jak/Stat signalling in methylcholanthrene-induced sarcomas.

Authors:  I M Svane; A M Engel; M Nielsen; O Werdelin
Journal:  Scand J Immunol       Date:  1997-10       Impact factor: 3.487

9.  Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes.

Authors:  Y J Lee; E N Benveniste
Journal:  J Immunol       Date:  1996-08-15       Impact factor: 5.422

10.  Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy.

Authors:  W Kern; T Haferlach; S Schnittger; W D Ludwig; W Hiddemann; C Schoch
Journal:  Leukemia       Date:  2002-10       Impact factor: 11.528

View more
  1 in total

1.  PCM1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature.

Authors:  Henry G Kaplan; Ruyun Jin; Carlo B Bifulco; James M Scanlan; David R Corwin
Journal:  Oncologist       Date:  2022-08-05       Impact factor: 5.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.